2005
DOI: 10.1016/j.virusres.2005.03.009
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of rabies biologics against new lyssaviruses from Eurasia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

7
109
0
3

Year Published

2006
2006
2023
2023

Publication Types

Select...
6
3

Relationship

3
6

Authors

Journals

citations
Cited by 157 publications
(119 citation statements)
references
References 27 publications
7
109
0
3
Order By: Relevance
“…For instance, when sera of EBLV-1 and EBLV-2 experimentally infected ferrets [34] were serologically investigated against EBLV-1 and EBLV-2, sera had lower neutralizing activity using the heterologous test virus (T. Müller et al, unpublished data). Similar reactions were reported from serological tests with Aravan virus (ARAV) and Khujand virus (KHUV) [51]. In this respect we are aware of the fact that by using one test virus only we may have missed seroconversion in other bat species, in particular in Myotis species.…”
Section: Discussionsupporting
confidence: 73%
“…For instance, when sera of EBLV-1 and EBLV-2 experimentally infected ferrets [34] were serologically investigated against EBLV-1 and EBLV-2, sera had lower neutralizing activity using the heterologous test virus (T. Müller et al, unpublished data). Similar reactions were reported from serological tests with Aravan virus (ARAV) and Khujand virus (KHUV) [51]. In this respect we are aware of the fact that by using one test virus only we may have missed seroconversion in other bat species, in particular in Myotis species.…”
Section: Discussionsupporting
confidence: 73%
“…Serologic cross-reactivity between LBV and MOKV has been demonstrated previously (Shope et al, 1970;Hanlon et al, 2005). Therefore, based on our cumulative serologic results, we have no substantive reason to consider the possibility of MOKV circulation in bats.…”
mentioning
confidence: 44%
“…Human consumption of bats is practiced in many parts of Nigeria, and the public health implication of this practice remains to be assessed. Surveillance is particularly important for nonrabies lyssaviruses because commercially available rabies biologics do not provide reliable protection against LBV, MOKV, and West Causcasian bat virus (WCBV) (Hanlon et al, 2005). In this study, we performed active surveillance for lyssaviruses among bats in the northern part of Nigeria in order to provide the baseline information necessary to begin assessment of the epidemiology of lyssaviruses in this part of the world.…”
mentioning
confidence: 99%
“…We have shown that LBV infection may be present in bat populations; consequently, we recommend appropriate precautions and use of proper personal protection equipment, such as gloves, when interacting with these animals. Even though the value of rabies vaccination is doubtful, it should be considered in light of the potential for cross-reactivity ( 15 ) and the lack of alternatives. Surveillance should be maintained as part of a strategy to better understand the epidemiology of LBV.…”
Section: Discussionmentioning
confidence: 99%